Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Retrobulbar corticotherapy].

M Bumbacher, A Roth

    Klinische Monatsblatter Fur Augenheilkunde
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Corticosteroid injections may improve vision in certain retinal vascular occlusions by reducing swelling. This treatment, combined with anticoagulation, shows promise for edematous and mixed venous thrombosis, but its benefits in other retinal conditions remain unclear.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetics and metabolism of the cholecystokinin antagonist dexloxiglumide in male human subjects.

    Xenobiotica; the fate of foreign compounds in biological systems·2003
    Same author

    Sexual activity cardiological survey on members of the Israel Heart Society.

    International journal of clinical practice·2003
    Same author

    [The function of Tenon's capsule revisited].

    Journal francais d'ophtalmologie·2003
    Same author

    Development and validation of a bioanalytical method for the determination of the cholecystokinin type-1 (CCK(1)) receptor antagonist dexloxiglumide in human plasma.

    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2002
    Same author

    [Optimizing histological image data for 3-D reconstruction using an image equalizer].

    Biomedizinische Technik. Biomedical engineering·2002
    Same author

    Nocardia pseudovaccinii sp. nov.

    International journal of systematic and evolutionary microbiology·2002
    Same journal

    Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

    Klinische Monatsblatter fur Augenheilkunde·2026
    Same journal

    [Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

    Klinische Monatsblatter fur Augenheilkunde·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Vascular Medicine

    Context:

    • Retinal vascular occlusions, including venous thrombosis, pose a significant risk to vision.
    • Corticosteroid therapy has been previously investigated for treating these conditions.

    Purpose:

    • To evaluate the efficacy of retrobulbar corticosteroid injections, combined with heparinotherapy, for various types of retinal vascular occlusions.
    • To assess the impact of reducing vascular wall edema on restoring blood flow and protecting retinal sensory cells.

    Summary:

    • Retrobulbar corticosteroid injections were administered regularly since 1975 for all retinal vascular occlusions.
    • The treatment aims to decrease vascular wall edema, improve blood flow, and protect sensory cells during repair.
    • Significant visual acuity improvement was observed in edematous or mixed venous thrombosis cases, particularly with central field loss.

    Related Experiment Videos

    Impact:

    • Corticosteroid therapy is indicated for edematous and mixed retinal venous thromboses with central vision loss.
    • The benefits in ischemic venous thrombosis, arterial occlusion, and vascular papillitis are less certain.
    • Corticosteroid therapy complements, but does not replace, anticoagulation, laser therapy, or general medical management.